Connect with us


Aragon puts out to tender therapeutic procedures for €11.9 million

Aragon puts out to tender the performance of therapeutic procedures for $14.2 million (€11.9 million). The maximum prices of the services already established vary from $1,000 (€850) to ten treatment sessions of complexity type I radiotherapy with conventional electron accelerators to $8,900 (€7,500) for brain radiosurgery.



Aragon seeks to shore up its healthcare system over the next four years. The regional government has put out to tender the performance of therapeutic procedures throughout the autonomous community for $14.2 million (€11.9 million), according to the region’s contractor profile. 

The contract, published this Thursday, March 11th, aims to select the companies in charge of performing external radiotherapy therapies and dermatology procedures over the next four years. The first lot, for external radiotherapy, includes therapies with conventional electron accelerators, treatments with special equipment, body irradiation, and proton therapy. The second lot, which refers to dermatology procedures, includes laser treatments and surgical procedures.  

If you want to read more on the subject and to find other important business news, download for free the Born2Invest mobile app.

The services performed in private centers, even if the users belong to the Aragon Health System, will follow nine guidelines

The first is an outpatient consultation for assessment and treatment planning, as well as explorations and complementary procedures. This will be followed by a pre-anesthesia consultation and the patient’s authorization for the procedure to be performed. 

The patient will then be admitted to the health center, the procedure will be prepared and the therapeutic procedure will be performed. After the stay in the center, the bidder will be responsible for possible complications of the procedure and their costs, if any, and post-treatment control consultations. 

The objectives of the external radiotherapy therapeutic procedure are to unify the criteria for action and treatment protocols, guaranteeing homogeneous care, unifying minority activities and making it possible to manage a single waiting list.  

The maximum prices of the services vary from $1,000 (€850) to $41,700 (€35,000)

The maximum prices of the services already established vary from $1,000 (€850) to ten treatment sessions of complexity type I radiotherapy with conventional electron accelerators to $8,900 (€7,500) for brain radiosurgery. The price of radiotherapy with special equipment ranges from $8,900 (€7,500) for brain tumors to $14,300 (€12,000) for lung or liver tumors. The stipulated prices performed with special equipment may be increased by up to 15% of the agreed price, together with the corresponding clinical and economic justification. 

The prices for proton therapy range from $34,500 (€29,000) for complete adult treatment to $41,700 (€35,000) for complete pediatric treatment. Finally, in the field of dermatology procedures, laser prices range from $1,800 (€1,500) to $5,660 (€4,750), while surgical procedures have a maximum stipulated price of $1,578 (€1,325).


(Featured image by javirue via Pixabay)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in PlantaDoce, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.

Eva Wesley is an experienced journalist, market trader, and financial executive. Driven by excellence and a passion to connect with people, she takes pride in writing think pieces that help people decide what to do with their investments. A blockchain enthusiast, she also engages in cryptocurrency trading. Her latest travels have also opened her eyes to other exciting markets, such as aerospace, cannabis, healthcare, and telcos.